Abeona Therapeutics Inc. (ABEO) vs Benitec Biopharma Inc. (BNTC)

A side-by-side comparison of Abeona Therapeutics Inc. and Benitec Biopharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABEO vs BNTC

growth of $100 · dividends reinvested · last 10y
ABEO -96.6% (-28.7%/yr)BNTC -97.4% (-30.5%/yr)ABEO compounded faster over this window
0100200300Start $10020182020202220242026$3$3
ABEO BNTC

ABEO vs BNTC: by the numbers

  • •BNTC is the larger company ($317M vs $291M market cap).
  • •Both run net losses; BNTC's is the smaller (0.00% vs -246.42% net margin).

Metrics side by side

Valuation

MetricABEOBNTC
P/S ratio11.41N/A
P/B ratio2.271.79

Profitability

MetricABEOBNTC
Gross margin73.68%0.00%
Operating margin-1536.91%0.00%
Net margin-246.42%0.00%
ROE-49.11%-25.73%
ROIC-49.76%-28.88%

Growth (annualized)

MetricABEOBNTC
Revenue CAGR (5Y)-10.26%N/A
Total return CAGR (5Y)-26.46%-31.08%

Frequently asked

How have ABEO and BNTC total returns compared?
Over the past 10 years, ABEO delivered -29.45% and BNTC delivered -30.49% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.